Now Launching

Introducing
|

An AI platform for the early detection of neurodegenerative conditions, years before symptoms appear. Built for hospitals. Designed for clinicians. Protecting patient privacy by default.

Learn More Get in Touch

The Problem

Diagnosis Comes Too Late

By the time most neurodegenerative disorders are diagnosed, irreversible damage has already occurred. Current diagnostic pathways are reactive. They wait for symptoms. Patients and clinicians deserve better.

What Diagonal Is

Early Detection That Works Within Existing Hospital Infrastructure

Diagonal is an AI-powered platform that detects neurodegenerative risk at the preclinical stage, before symptoms emerge and before irreversible damage is done. It works with data hospitals are already collecting, requires no additional tests upfront, and keeps patient information where it belongs: inside the institution.

How It Works

From Existing Data to Early Action

Works With Data You Already Have

Diagonal plugs into existing hospital systems and analyzes patient data that is already being collected. No new tests. No new equipment. No disruption to clinical workflows.

Patient Data Stays In Your Hospital

Diagonal was built from the ground up so that patient data never leaves the institution. Hospitals collaborate through the platform without ever sharing raw patient records.

Clinicians Get Actionable Risk Profiles

When Diagonal detects preclinical risk, it delivers clear, interpretable reports that clinicians can act on. Confirmatory testing is recommended only when the evidence supports it.

Why It Matters

Real-World Impact

For Patients

A Chance at Early Intervention

Millions of people are living with undetected neurodegenerative conditions. Diagonal gives them a window to act, years before symptoms take hold, when interventions and planning can make the most difference.

For Clinicians

Insight Without Extra Burden

Diagonal does not add tests or workflows. It surfaces risk from data already in the system and presents it in a format designed for clinical decision-making, not research interpretation.

For Hospitals

Privacy-Preserving by Design

Patient data never leaves the institution. Diagonal was architected for regulatory environments like HIPAA, GDPR, and DISHA, so hospitals can participate without compromising governance or compliance.

For Healthcare Systems

Shifting Diagnosis Upstream

Late-stage neurodegeneration is one of the most expensive conditions to manage. Diagonal moves detection to the preclinical stage, opening the door to earlier care pathways and reducing downstream burden.

Built By

CoralAI Research

Diagonal is built by CoralAI Research (CAIR), a healthtech startup based in Hyderabad, India. Founded by a team spanning data science, clinical medicine, and computational physics, CAIR is focused on making early diagnosis accessible and equitable.

Visit coralairesearch.com

Get in Touch

The Future of Diagnosis Starts Before Symptoms Do

We are looking to connect with hospitals, research institutions, and collaborators who share our vision for early detection.